Search research articles
Contact Us
Filters
Showing results (511-520 of 522) with videos related to
Page
of 53
Sort By:
Hepatology (Baltimore, Md.)
|
April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Pierre Nahon, Marianne Ziol, Long Pan, et al.
Journal of the American College of Cardiology
|
April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
Tullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
European Journal of Epidemiology
|
April 16, 2024
Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection
Valentin Goutaudier, Marta Sablik, Maud Racapé, et al.
JAMA
|
August 30, 2024
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial
Matthieu Legrand, Jérémy Falcone, Bernard Cholley, et al.
Lancet (London, England)
|
September 2, 2016
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
Guillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Plos One
|
December 16, 2020
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study
Raphael Borie, Laurent Savale, Antoine Dossier, et al.
The New England Journal of Medicine
|
April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolism
Guy Meyer, Eric Vicaut, Thierry Danays, et al.
The New England Journal of Medicine
|
August 30, 2024
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Johanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
Circulation
|
June 10, 2026
Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial
Michel Zeitouni, Niki Procopi, Guillaume Cayla, et al.
The New England Journal of Medicine
|
March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Isabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Page
of 53
Search research articles
Search
Showing results (511-520 of 522) with videos related to
Sort By:
Page
of 53
Hepatology (Baltimore, Md.)
|
April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Pierre Nahon, Marianne Ziol, Long Pan, et al.
Journal of the American College of Cardiology
|
April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
Tullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
European Journal of Epidemiology
|
April 16, 2024
Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection
Valentin Goutaudier, Marta Sablik, Maud Racapé, et al.
JAMA
|
August 30, 2024
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial
Matthieu Legrand, Jérémy Falcone, Bernard Cholley, et al.
Lancet (London, England)
|
September 2, 2016
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
Guillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Plos One
|
December 16, 2020
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study
Raphael Borie, Laurent Savale, Antoine Dossier, et al.
The New England Journal of Medicine
|
April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolism
Guy Meyer, Eric Vicaut, Thierry Danays, et al.
The New England Journal of Medicine
|
August 30, 2024
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Johanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
Circulation
|
June 10, 2026
Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial
Michel Zeitouni, Niki Procopi, Guillaume Cayla, et al.
The New England Journal of Medicine
|
March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Isabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Page
of 53